Low-Volume Aseptic Filling Using a Linear Peristaltic Pump.

Aseptic filling Filling systems Low-volume filling Microdosing Proteins Pumps Single-use technology

Journal

PDA journal of pharmaceutical science and technology
ISSN: 1948-2124
Titre abrégé: PDA J Pharm Sci Technol
Pays: United States
ID NLM: 9439538

Informations de publication

Date de publication:
Historique:
pubmed: 18 10 2020
medline: 29 10 2021
entrez: 17 10 2020
Statut: ppublish

Résumé

The pharmaceutical industry has been confronted with new and complex challenges, particularly with regard to the aseptic filling of parenterals, including monoclonal antibodies and ophthalmologic drugs designed for intravitreal injections, which often require fill volumes <200 µL. In addition to intravitreal administration, microliter doses may be required for applications using highly concentrated formulations and cell and gene therapies. Many of these therapies have either a narrow or unknown therapeutic window, requiring a high degree of accuracy and precision for the filling system. This study aimed to investigate the applicability of a linear peristaltic pump as a novel and innovative filling system for the low-volume filling of parenterals, compared with the state-of-the-art filling systems that are currently used during pharmaceutical production. We characterized the working principle of the pump and evaluated its accuracy for a target fill volume of 50 µL. Our results demonstrated that the linear peristaltic pump can be used for fill volumes ranging from 12 to 420 µL. A deeper investigation was performed with the fill volume of 50 µL, because it represents a typical clinical dose of an intravitreal application. The filling accuracy was stable over an 8 h operation time, with a standard deviation of +/-4.4%. We conclude that this technology may allow the pharmaceutical industry to overcome challenges associated with the reliable filling of volumes <1 mL during aseptic filling. This technology has the potential to change aseptic filling methods by broadening the range of potential fill volumes while maintaining accuracy and precision, even when performing microliter fills.

Identifiants

pubmed: 33067332
pii: pdajpst.2020.011858
doi: 10.5731/pdajpst.2020.011858
doi:

Substances chimiques

Antibodies, Monoclonal 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

245-257

Informations de copyright

© PDA, Inc. 2021.

Auteurs

Tim Dreckmann (T)

F. Hoffmann-La Roche Ltd., Grenzacherstrasse 124, 4070 Basel, Switzerland; and tim.dreckmann@roche.com.
University of Basel, Division of Pharmaceutical Technology, Department of Pharmaceutical Sciences, 4056 Basel.

Imke-Sonja Ludwig (IS)

F. Hoffmann-La Roche Ltd., Grenzacherstrasse 124, 4070 Basel, Switzerland; and.

Joerg Luemkemann (J)

F. Hoffmann-La Roche Ltd., Grenzacherstrasse 124, 4070 Basel, Switzerland; and.

Joerg Huwyler (J)

University of Basel, Division of Pharmaceutical Technology, Department of Pharmaceutical Sciences, 4056 Basel.

Articles similaires

Using Bayh-Dole Act March-In Rights to Lower US Drug Prices.

Lisa Larrimore Ouellette, Bhaven N Sampat
1.00
United States Cross-Sectional Studies Patents as Topic Humans Drugs, Generic
Humans Amyotrophic Lateral Sclerosis Male Middle Aged Female
Animals Rumen Methane Fermentation Cannabis
Humans Epitopes Antibodies, Monoclonal Immunoglobulin Fab Fragments Cryoelectron Microscopy

Classifications MeSH